April 21 -
** HALLIBURTON CO, Thursday close $60.9
The oilfield services company reported a profit for the first quarter, compared with a loss a year earlier when it booked a pre-tax charge of $1 billion related to the Gulf of Mexico spill.
** HASBRO INC, Thursday close $54.61
The toymaker reported a quarterly profit, compared with a year-ago loss, helped by strong demand for its toys for girls. The company’s first-quarter revenue rose 2 percent to $679.5 million.
** GENERAL MOTORS CO, Thursday close $33.98
The U.S. car giant plans to invest $12 billion in China from 2014 to 2017 and build more plants next year as it competes with aggressive rivals in the world’s largest auto market.
** NEWMONT MINING CORP, Thursday close $23.54
The talks between Barrick Gold Corp and Newmont Mining over a combination that would create a gold mining behemoth have hit a snag, but two sources close to the situation say the companies remain keen on a deal and discussions are likely to resume.
** PFIZER INC, Thursday close $30.25
The U.S. pharmaceutical giant has approached British rival AstraZeneca Plc to propose a 60 billion pound ($101 billion) takeover, Britain’s Sunday Times reported.
** APPLE INC, Thursday close $524.94
** GOOGLE INC, Thursday close $543.34
Apple and Google are wooing game developers to ensure that top game titles arrive first on devices powered by their respective operating system, the Wall Street Journal reported, citing people familiar with the matter.
** KRAFT FOODS GROUP INC, Thursday close $56.91
Kraft Foods is recalling about 96,000 pounds of Oscar Mayer Classic Wieners because the packages may instead contain Classic Cheese Dogs made with milk, a known allergen.
** COMCAST CORP, Thursday close $49.1
** CHARTER COMMUNICATIONS INC, Thursday close $56.91
Comcast is in talks with Charter Communications over selling or spinning off roughly 3 million subscribers worth approximately $18 billion to $20 billion as part of the divestitures related to its $45.3 billion takeover of Time Warner Cable, according to a source familiar with the matter.
** VIMPELCOM LTD, Thursday close $9
Russia’s Vimpelcom has resolved a long-running dispute with the Algerian government by selling it a majority stake in the country’s biggest telecoms operator for $2.6 billion, while it will keep control and slash debt.
** AMERICAN TOWER CORP, Thursday close $82.65
Indian conglomerate Reliance Industries Ltd’ telecommunications unit, which holds nationwide 4G permits, has agreed to lease mobile phone masts from infrastructure provider American Tower Corp’s local arm, the companies said in a statement on Monday.
** WALT DISNEY CO, Thursday close $79.99
Walt Disney Co’s cable networks are expected to record high single-digit growth in operating income and domestic affiliate revenue from fiscal 2014 through 2016, Chief Financial Officer Jay Rasulo told investors on Thursday.
** SPRINT CORP, Thursday close $8.52
** T-MOBILE US INC, Thursday close $30.4
A possible merger between Sprint and T-Mobile could prompt U.S. regulators to rewrite rules they are now weighing for a 2015 auction of airwaves, according to sources familiar with the proposed regulations.
** LULULEMON ATHLETICA INC, Thursday close $51.71
A U.S. judge has issued final dismissals of lawsuits accusing Lululemon and various company officials of defrauding shareholders by concealing defects in yoga pants.
** CHINDEX INTERNATIONAL INC, Thursday close $22.94
Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed Chindex International Inc by 15 percent to $223.6 million after a bidding war for the China-focused hospital chain.
** ATHENAHEALTH, Thursday close $145.58
The healthcare IT services company on Thursday reported first-quarter adjusted earnings and revenue that fell below Wall Street estimates.
Three brokerages, including Oppenheimer, Deutsche Bank and B. Riley cut their price targets on the company’ stock, citing weakness in its Epocrates business - a mobile medical application.
** SAREPTA THERAPEUTICS INC, Thursday close $24.4
The company said it would start new trials to revive the chance of approval for its experimental muscle disorder drug after the U.S. Food and Drug Administration advised the company to submit new safety and efficacy data.
** SELECT COMFORT CORP, Thursday close $17.75, + 3.3 pct after market
The specialty mattress maker on Thursday reported first-quarter sales that beat analysts’ estimates, helped by a 2 percent rise in comparable sales.
** PEOPLE‘S UNITED FINANCIAL INC, Thursday close -100.00
Brokerage Keefe Bruyette & Woods cut the lender’s target price to $14.50 from $15, citing low profitability until the company improves return on assets and efficiency ratio.
** PRIVATEBANCORP INC, Thursday close $29.59
KBW raised its price target on the stock to $34 from $33 after the bank reported better-than-expected first quarter results on Thursday, helped by commercial loan growth.
** LINEAR TECHNOLOGY CORP, Thursday close $46.37
The analog chipmaker said on Thursday it expects revenue to grow 2-6 percent from $348 million in the third quarter, that is $355-$369 million. Analysts on average were expecting revenue of $365 million, according to Thomson Reuters I/B/E/S.
** RADIOSHACK CORP, Thursday close $0
The struggling U.S. electronics chain is mired in talks with its lenders over its plans to close about 1,100 stores, complicating its turnaround efforts, the Wall Street Journal reported, citing sources close to the talks.
RadioShack, which operates about 4,300 stores in the United States, said in March that the plan needed permission from its lenders, adding that its credit agreements allowed it to close only about 200 stores without the approval of lead lenders, the Journal said late on Wednesday. (r.reuters.com/vyg68v)
The company reported a wider quarterly loss and a huge drop in sales during the holiday season.
** WEIBO CORP, Thursday close $20.24
The Chinese Twitter-like messaging service company’s U.S.-listed shares were up premarket on Monday after they soared 19 percent on their debut on Thursday.
** BIOGEN IDEC INC, Thursday close $290.54
Biogen is pricing its newly approved long-acting hemophilia drug, Alprolix, to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.
The move could pressure rivals such as Pfizer Inc to lower prices for existing hemophilia treatments, which provide patients with life-saving infusions of a blood clotting agent, according to doctors and industry analysts.
** UNITEDHEALTH GROUP INC, Thursday close $75.78
The largest U.S. health insurer, said it spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc GILD.O in its first three months on the market, an amount that was “multiple” times what it had expected.
** ABBOTT LABORATORIES, Thursday close $38.93
An Abbott Laboratories spinoff urged a federal appeals court to revisit a ruling in a case against GlaxoSmithKline Plc , but without disturbing landmark constitutional protections for gays and lesbians.
** PLATINUM UNDERWRITERS HOLDINGS LTD, Thursday close $62.16, -100.00 pct premarket
Brokerage Keefe Bruyette & Woods raised the reinsurance provider’s target price to $69 from $67, after the company’s earnings for the quarter ended March 31 beat analysts’ estimates with strong underwriting, investing, and capital management performance. The company reported earnings per share of $2.27, higher than analysts’ average estimate of $1.28, according to Thomson Reuters I/B/E/S. [ID: nPn5HRfMd] (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)